We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

ERT Appoints Robert Kleiman MD to Chief Medical Officer

ERT Appoints Robert Kleiman MD to Chief Medical Officer

ERT Appoints Robert Kleiman MD to Chief Medical Officer

ERT Appoints Robert Kleiman MD to Chief Medical Officer

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ERT Appoints Robert Kleiman MD to Chief Medical Officer"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, has announced that Robert Kleiman, M.D. has been appointed to the role of Chief Medical Officer in addition to his current role as Vice President of Global Cardiology.

Dr. Kleiman graduated from Brown University Medical School with residency in Internal Medicine and completed Fellowships in Cardiology and Cardiac Electrophysiology at the University of Pennsylvania.

Prior to joining ERT as a full time employee in April 2004, Dr. Kleiman had worked for ERT as an independent contractor through his cardiology and cardiac electrophysiology practice since 1994.

Dr. Kleiman has managed ERT’s cardiology group, which has more than tripled in size since 2004, while maintaining ERT’s standards for high quality and consistency.

In addition to his current duties as Vice President of Global Cardiology, Dr. Kleiman will be responsible for assuming an increasing consulting and sales role.

“Dr. Kleiman combines remarkable industry expertise with years of experience in the hospital practice environment. These factors, coupled with his in-depth knowledge of our business operations, make him a perfect candidate for the position,” commented Dr. Jeffrey Litwin, President and Chief Executive Officer of ERT.

Litwin continued, “I would like to thank Bob for his dedicated service over the past eight years and congratulate him on this well deserved promotion. All of our employees look forward to continuing to work with him as he expands his role at ERT”.

Commenting on his appointment Dr Kleiman noted “I have enjoyed my long association with ERT and very much look forward to working with our customers and staff in my new role of working more closely with sponsors to ensure the efficacy and safety of new drugs”.